I’ve purchased from other india vendors before is this vendor pretty fast and reliable (assuming you live in the US)? Can I ask if you have a brand preference? Ive only tried Modalert and it was good but have read online its hit or miss.
I’ve been using modafinil for the past few days as I’ve got a lot of work to get done. A method I found to make sure it doesn’t interrupt sleep is have it right by your bedside and the moment you wake up and there is sunlight at all coming through your window, take it before getting out of bed.
It’s winter in Australia, I tend to not get out of bed the moment I wake up anyway.
Combined with high dose taurine, glycine and melatonin I’ve had no issues sleeping. If anything I feel like I’m sleeping better.
3 Likes
I’ve worked in health care for 30 years as a therapist and an RN. I don’t know where you get that “barely anyone takes their BP meds” but I’ve not seen that. I have thought the opposite— they take the pill but they don’t CHECK their BP first. Some, as they get older, have slowed down and their BP has lowered and they are still taking it and bottoming out and not knowing why. They just blindly do what they are told “take your pill” without using any common sense. That is much more the typical patient that I see.
1 Like
Adderall is by far the best for focus and productivity. However, it may not be the best for health.
4 Likes
I could see this. I had to stop taking mine because my BP was getting too low. The difference is I have a monitor at home to track it.
There’s studies on compliance, and it’s usually low, around ~50% or lower, your case can be explained that the patients that healthcare sees more often is different from people in total.
Interesting, I might look for the studies. My thought is they comply with a pill but not lifestyle b/c usually what I am trying to teach is getting better habits for your balance and strength and controlling your diabetes etc. My heart is absolutely in getting people to understand how quickly health can deteriorate after an illness, hospitalization, surgery or whatever if you don’t go into it relatively healthy. But I estimate 1 in 10 really cares to take charge. 
I’m going to attach the usual TL,DR of the whole thread up to now. This attachment constitutes both a summary and a critical evaluation, by GPT 5.6 Sol Extra-high, one of the two top existing LLMs, of what has been said throughout the thread.
modafinil_long_term_forum_sota_review_2026-07-20.pdf (81.6 KB)
3 Likes
It’s why long lasting medications that is used infrequently have been developed like yearly zoledronic acid or inclisiran. Yeah compliance for lifestyle changes are worse than drugs, so on net drugs are fantastic, like the GLP-1/+ agonists for obesity.
If you mean medication adherence (also called compliance) for people with chronic conditions, the commonly cited estimate is:
- About 50% of people with chronic diseases in developed countries take their medications as prescribed over the long term.
- This means roughly half of patients are non-adherent, whether by missing doses, stopping treatment early, or not taking medications at the prescribed frequency.
This estimate comes from the World Health Organization and has been supported by many subsequent studies.
Adherence varies substantially by condition:
Chronic condition Typical adherence Hypertension 50–60% Diabetes 50–70% High cholesterol 40–60% Asthma/COPD 30–70% HIV (modern treatment programs) Often >80–90% with support Osteoporosis 30–50% after 1 year Factors that reduce adherence include:
- Complex medication regimens
- Side effects
- Medication cost
- Forgetfulness
- Limited understanding of the disease
- Depression or cognitive impairment
- Lack of symptoms (e.g., high blood pressure)
Improving adherence can significantly reduce hospitalizations, complications, and healthcare costs. Some studies estimate that better adherence could prevent a substantial proportion of avoidable complications from chronic disease.
So, if you’re looking for a single benchmark, 50% adherence is the standard figure most often cited for chronic disease medications.
Hypothesis: If the S-enantiomer is what gives modafinil its stronger initial “kick”, then selectively redosing S-modafinil 3 to 5 hours later could theoretically maintain that effect without substantially increasing the long-lasting R-modafinil that tends to interfere with sleep.
The problem is that pure S-modafinil isn’t commercially available (as far as I’m aware), so this is mostly a thought experiment.
The idea came from seeing an X post claiming that modafinil is actually superior to armodafinil specifically because it contains the S-enantiomer.
For context, modafinil is a 50:50 mixture of R- and S-modafinil. The S-enantiomer is eliminated much more rapidly (roughly a 3 to 5 hour half life), whereas the R-enantiomer has a much longer half life (around 12 to 15 hours). Armodafinil contains only the R-enantiomer.
Many people also report that armodafinil feels “cleaner” and smoother, while modafinil has a stronger initial kick or even a slightly “dirtier” feel. That’s anecdotal, of course, but it’s a surprisingly common observation.
The conservative explanation is simply pharmacokinetics. Modafinil exposes you to both enantiomers initially, whereas armodafinil does not. Different concentration-time curves alone could explain the subjective differences.
But if the S-enantiomer contributes something qualitatively useful, then it raises an interesting question.
After 3 to 5 hours, much of the S-modafinil has been eliminated while plenty of the original R-modafinil remains. If you could selectively replace only the S-enantiomer at that point, you might restore the early-phase effects without significantly extending the duration of wakefulness.
To be clear, I’m not claiming S-modafinil has unique pharmacological effects. As far as I know, there are very few direct human studies comparing the subjective effects of isolated R- and S-modafinil, so the differences between modafinil and armodafinil could be entirely explained by pharmacokinetics.
Has anyone come across research comparing the isolated enantiomers beyond pharmacokinetics, or is there any evidence that S-modafinil contributes something qualitatively different from R-modafinil?
1 Like
Not good. Modafinil would be so much better if it didn’t cause insomnia
On top of insomnia, it made me unnecessarily emotional. I didn’t like the feeling.